Charles River Laboratories International Earnings

Charles River Laboratories International’s revenue fell -1.08% since last year same period to $1002.55Mn in the Q4 2024. On a quarterly growth basis, Charles River Laboratories International has generated -0.71% fall in its revenue since last 3-months.

Charles River Laboratories International’s net profit fell -214.07% since last year same period to $-213.41Mn in the Q4 2024. On a quarterly growth basis, Charles River Laboratories International has generated -410.74% fall in its net profits since last 3-months.

Charles River Laboratories International’s net profit margin fell -215.32% since last year same period to -21.29% in the Q4 2024. On a quarterly growth basis, Charles River Laboratories International has generated -412.98% fall in its net profit margins since last 3-months.

Charles River Laboratories International’s earning per share (EPS) estimates for the current quarter stand at 2.53 - a 4.02% jump from last quarter’s estimates.

Charles River Laboratories International’s earning per share (EPS) estimates for the current year stand at 2.53.

Charles River Laboratories International’s earning per share (EPS) jumped 8.13% since last year same period to 2.66 in the Q4 2024. This indicates that the Charles River Laboratories International has generated 8.13% annual rate of jump in its earning per share (EPS) in the last 4 quarters.